Cargando…
Validation of Risk-Adapted Venous Thromboembolism Prediction in Multiple Myeloma Patients
Multiple myeloma (MM) is associated with an increased risk of venous thrombosis (VTE). In the United Kingdom Medical Research Council (MRC) XI study of patients treated with immunomodulatory therapy, the VTE rate was 11.8% despite 87.7% of the patients being on thromboprophylaxis at the time of thro...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396929/ https://www.ncbi.nlm.nih.gov/pubmed/34441832 http://dx.doi.org/10.3390/jcm10163536 |